Rosa Rademakers and Bryan Traynor received this year’s Breakthrough Prize for identifying the most common genetic cause of ...
The short film, titled "Ring Every Bell," chronicles Eric Dane's advocacy efforts through his work with I AM ALS to fight ...
Jeff Vierstra's mother and two sisters all died following complications from ALS, or Amyotrophic Lateral Sclerosis, but the scientist and skier is hoping an experimental treatment and the first known ...
Jon LaPook, M.D. is the award-winning chief medical correspondent for CBS News. Since joining CBS News in 2006, LaPook has delivered more than 1,200 reports on a wide variety of breaking news and ...
Shionogi & Co. announced April 1 it completed the transfer of rights of Lou Gehrig’s disease treatments from the Jersey City-based subsidiary of Tanabe Pharma Corp. As part of the $2.5 billion deal, ...
A new global initiative launched today aims to close a critical gap in ALS/MND drug discovery - current cell models used for testing treatments do not currently reflect the diverse nature of the ...
PREVAiLS is a pivotal, global, 500-participant Phase 3 study to evaluate efficacy and safety of pridopidine, an investigational drug, in slowing ALS progression (ALSFRS-R) in early, rapidly ...
Amyotrophic lateral sclerosis (ALS) first garnered widespread attention in 1939, when New York Yankees baseball player Lou Gehrig was diagnosed with the neurogenerative disease. Over the decades, ...
With the help of artificial intelligence, a coalition of Bay Area institutions identified 18 FDA-approved drugs that could improve the lives of those suffering from amyotrophic lateral sclerosis, ...
This is read by an automated voice. Please report any issues or inconsistencies here. Film producer Andrew Gunn died Monday following a battle with ALS at age 56. Gunn is best known for his work on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results